Szemészet, 2003 (140. évfolyam, 1-4. szám)
2003-09-01 / 3. szám
140. évfolyam (2003) 18! Irodalom 1. Anderson D.F., Ellies R, Pires R.T.F.: Amniotic membrane transplantation for partial limbal stem cell deficiency. Br J Ophthalmol 2001; 85: 567-575. 2. Anderson D.F., Prabhasawat P, Alfonso E.: Amniotic membrane transplantation after the primary surgical management of band keratopathy. Cornea 2001; 20: 354-361. 3. Buhmann S., You L, Spandau U.: Amniotic membrane downregulates chemokine expression in human keratocytes. Invest Ophthalmol Vis Sei 1999; 40: S578. 4. Choi Y.S., Kim J.Y., Wee W.R.: Effect of the application of human amniotic membrane on rabbit corneal wound healing after excimer laser photorefractive keratectomy. Cornea 1998; 17: 389-395. 5. Fujishima H„ Shimazaki J., Shinozaki N.: Trabeculectomy with the use of amniotic membrane for uncontrollable glaucoma. Ophthalmic Surgery Lasers 1998; 29: 428-431. 6. Fukuda K., Chikama T, Nakamura M.: Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea and conjunctiva. Cornea 1999; 18: 73-79. 7. Hao YX, Ma DHK, Kim IPS.- Identification of anti-neovascularization proteins in human amniotic membrane, Cornea 2000; 19: 348-352. 8. Kerényi Á.: Pterygium műtét autolog conjunctiva/limbus transzplantációval. Szemészet 1993; 130: 71-73. 9. Kerényi Á.: Mitomycin C intraoperativ alkalmazása pterygium műtéteknél. Szemészet 2000; 137: 35-38. 10. Kim J.C., Tseng S.C.G.: Transplantation of preserved human amniotic membrane for surface reconstruction in severly damaged rabbit corneas. Cornea 1995; 14: 473-484. 11. Koizumi N., Ínatomi T, Sotozono C.: Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Research 2000; 20: 173-177. 12. Kubo M., Sonoda Y, Muramatsu R.: Immunogenicity of human amniotic membrane in experimental xenotransplantation. Invest Ophthalmol Vis Sei 2001: 42: 1539-1546. 13. Lee S.H., Tseng S.C.G.: Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 1997; 123: 303-312. 14. Letko E„ Stechschulte S.U., Kenyon K.R.: Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch Ophthalmol 2001; 119: 659-663. 15. Ma D.H.K., See L.C., Паи S.B.: Amniotic membrane graft for primary pterygium: comparison with conjunctival autograft and topical mitomycin C treatment. Br J Opthalmol 2000; 84: 973-978. 16. Meller D„ Pires R.T.F., Tseng S.C.G.: Ex vivo preservation and expansion of human limbal epithelial progenitor cells by amniotic membrane. Invest Ophthalmol Vis Sei 1999; 40: S329. 17. Paridaens D„ Beekhuis H„ Bosch W.: Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia. Br J Ophthalmol 2001; 85: 658-661. 18. Prabhasawat P, Barton K., Burkett G.: Comparison of conjunctival autografts, amniotic membrane grafts, and primary closure for pterygium excision. Ophthalmology 1997; 104: 974-985. 19. de Rötth A.: Plastic repair of conjunctival defects with fetal membranes. Arch Opthalmol 1940; 23: 522-525. 20. Shimazaki J., Yang H.Y., Tsubota K.: Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns. Ophalamology 1997; 104: 2068-2076. 21. Shimazaki J., Shinozaki N., Tsubota K.: Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with Symblepharon. Br J Opthalmol 1998; 82: 235-240. 22. Shimmura S., Shimazaki J., Ohashi Y: Antiinflammatory effect of amniotic membrane transplantation in ocular surface disorders. Cornea 2001; 20: 408-411. 23. Solomon A., Pires R.T.F., Tseng S.C.G.: Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology 2001; 108: 449-460. 24. Tseng S.C.G., Prabhasawat P, Lee S.H.: Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol 1997; 124: 765-774. 25. Tseng S.C.G., Li D.G., Ma X.: Suppression of transforming growth factor-beta isoforms, TGF-ß receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblast by amniotic membrane matrix. J Cell Physiol 1999; 179: 325-335. 26. Tseng S.C.G., Tsubota K.: Important concepts fot treating ocular surface and tear disorders. Am J Ophthalmol 1997; 124: 825-835. 27. Tsubota K„ Satake Y., Ohyama M.: Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Steven- Johnson syndrome. Am J Ophthalmol 1996; 122: 38-52. 28. Uchida S., Suzuki Y, Araié M.: Factors secreted by human amniotic epithelial cells promote the survival of purified rat retinal ganglion cells. Invest Ophthalmol Vis Sei 2001; 42: S750. A szerző levelezési címe: Dr. Kerényi Ágnes Főv. Önkorm. Bajcsy-Zsilinszky Kh., Szemészeti osztály 1106 Budapest, Maglódi út 89-91. AMNIONTRANSZPLANTÁCIÓ A SZARUHÁRTYA BETEGSÉGEINEK KEZELÉSÉBEN
